Literature DB >> 21906157

Multiple cutaneous plexiform schwannomas as initial presentation of neurofibromatosis 2 in a 9-year-old.

Tien V Nguyen1, Mark R Matthews, Fernando F Barrera, John C Browning.   

Abstract

Neurofibromatosis 2 (NF2) is an autosomal-dominant disease caused by genetic mutations of the NF2 gene on chromosome 22. Patients are often diagnosed according to the presence of bilateral vestibular schwannomas and other tumors in the brain and spinal cord. In children, NF2 can present early with ocular findings and cutaneous tumors. We report here a 9-year-old girl who presented with multiple pigmented, slightly tender plaques on her scalp, face, and back that were revealed by histopathology to be plexiform schwannomas. We suspected NF2 and sent the patient's blood for genetic testing, which confirmed our diagnosis.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21906157     DOI: 10.1111/j.1525-1470.2011.01532.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  3 in total

1.  Early Genetic Diagnosis of Neurofibromatosis Type 2 From Skin Plaque Plexiform Schwannomas in Childhood.

Authors:  Elisabeth Castellanos; Adrià Plana; Cristina Carrato; Meritxell Carrió; Inma Rosas; Emilio Amilibia; Francesc Roca-Ribas; Cristina Hostalot; Alicia Castillo; Andrea Ros; Ariadna Quer; Juan Luis Becerra; Hector Salvador; Conxi Lázaro; Ignacio Blanco; Eduard Serra; Isabel Bielsa
Journal:  JAMA Dermatol       Date:  2018-03-01       Impact factor: 10.282

Review 2.  Gastric plexiform schwannoma in association with neurofibromatosis type 2.

Authors:  Satoru Kudose; Michael Kyriakos; Michael Magdi Awad
Journal:  Clin J Gastroenterol       Date:  2016-09-30

3.  Skin lesions in neurofibromatosis type 2: diagnostic and prognostic significance of cutaneous (plexiform) schwannomas.

Authors:  A Plana-Pla; B García; M Munera-Campos; N Catasus; E Serra Arenas; I Blanco; E Castellanos Perez; I Bielsa
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-05-21       Impact factor: 9.228

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.